T 0617/07 (Monoclonal NGF-antagonist antibodies/LAY LINE) of 04.08.2009
- European Case Law Identifier
- ECLI:EP:BA:2009:T061707.20090804
- Date of decision
- 4 August 2009
- Case number
- T 0617/07
- Petition for review of
- -
- Application number
- 00935482.0
- IPC class
- C07K 16/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as NGF-antagonist molecules
- Applicant name
- Lay Line Genomics SpA
- Opponent name
- Astrazeneca UK Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83
- Keywords
- Added matter, extension of protection (no)
Sufficiency of disclosure, novelty, inventive step (yes) - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent on the basis of the New Main Request as filed during the oral proceedings before the board and a description to be adapted thereto.